ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with

Lillian M Smyth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.